世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Bladder Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3914
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、98ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、膀胱がん分子病理学診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・膀胱がん分子病理学診断の市場動向
・企業の競争状況、市場シェア
・膀胱がん分子病理学診断の種類別市場規模と予測2016-2027（PCR、FISH、DNAシーケンシング、ジーンチップ）
・膀胱がん分子病理学診断の用途別市場規模と予測2016-2027（臨床診断、薬物スクリーニング、研究所）
・膀胱がん分子病理学診断の北米市場規模2016-2027（アメリカ、カナダ）
・膀胱がん分子病理学診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・膀胱がん分子病理学診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・膀胱がん分子病理学診断の中南米市場規模2016-2027（メキシコ、ブラジル）
・膀胱がん分子病理学診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Genetech、Gpmedical、Gene+、DMDbiomed、Annoroad、Topgen、Geneis、Unitedgene、Inmedi）
・結論

A molecular approach for diagnosing bladder cancer

Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market
The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bladder Cancer Molecular Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bladder Cancer Molecular Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bladder Cancer Molecular Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bladder Cancer Molecular Diagnostics market.

Global Bladder Cancer Molecular Diagnostics Scope and Market Size
Bladder Cancer Molecular Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bladder Cancer Molecular Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
PCR
FISH
DNA Sequencing
Gene Chip

Segment by Application
Clinical Diagnosis
Drug Screening
Research

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Genetech
Gpmedical
Gene+
DMDbiomed
Annoroad
Topgen
Geneis
Unitedgene
Inmedi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bladder Cancer Molecular Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 PCR
1.2.3 FISH
1.2.4 DNA Sequencing
1.2.5 Gene Chip
1.3 Market by Application
1.3.1 Global Bladder Cancer Molecular Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinical Diagnosis
1.3.3 Drug Screening
1.3.4 Research
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Bladder Cancer Molecular Diagnostics Market Perspective (2016-2027)
2.2 Bladder Cancer Molecular Diagnostics Growth Trends by Regions
2.2.1 Bladder Cancer Molecular Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Bladder Cancer Molecular Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Bladder Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Bladder Cancer Molecular Diagnostics Industry Dynamic
2.3.1 Bladder Cancer Molecular Diagnostics Market Trends
2.3.2 Bladder Cancer Molecular Diagnostics Market Drivers
2.3.3 Bladder Cancer Molecular Diagnostics Market Challenges
2.3.4 Bladder Cancer Molecular Diagnostics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Bladder Cancer Molecular Diagnostics Players by Revenue
3.1.1 Global Top Bladder Cancer Molecular Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Bladder Cancer Molecular Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Bladder Cancer Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bladder Cancer Molecular Diagnostics Revenue
3.4 Global Bladder Cancer Molecular Diagnostics Market Concentration Ratio
3.4.1 Global Bladder Cancer Molecular Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bladder Cancer Molecular Diagnostics Revenue in 2020
3.5 Bladder Cancer Molecular Diagnostics Key Players Head office and Area Served
3.6 Key Players Bladder Cancer Molecular Diagnostics Product Solution and Service
3.7 Date of Enter into Bladder Cancer Molecular Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Bladder Cancer Molecular Diagnostics Breakdown Data by Type
4.1 Global Bladder Cancer Molecular Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Bladder Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027)

5 Bladder Cancer Molecular Diagnostics Breakdown Data by Application
5.1 Global Bladder Cancer Molecular Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Bladder Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Bladder Cancer Molecular Diagnostics Market Size (2016-2027)
6.2 North America Bladder Cancer Molecular Diagnostics Market Size by Type
6.2.1 North America Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2027)
6.3 North America Bladder Cancer Molecular Diagnostics Market Size by Application
6.3.1 North America Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2027)
6.4 North America Bladder Cancer Molecular Diagnostics Market Size by Country
6.4.1 North America Bladder Cancer Molecular Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Bladder Cancer Molecular Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Bladder Cancer Molecular Diagnostics Market Size (2016-2027)
7.2 Europe Bladder Cancer Molecular Diagnostics Market Size by Type
7.2.1 Europe Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2027)
7.3 Europe Bladder Cancer Molecular Diagnostics Market Size by Application
7.3.1 Europe Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2027)
7.4 Europe Bladder Cancer Molecular Diagnostics Market Size by Country
7.4.1 Europe Bladder Cancer Molecular Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Bladder Cancer Molecular Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Type
8.2.1 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Application
8.3.1 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Region
8.4.1 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Bladder Cancer Molecular Diagnostics Market Size (2016-2027)
9.2 Latin America Bladder Cancer Molecular Diagnostics Market Size by Type
9.2.1 Latin America Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Bladder Cancer Molecular Diagnostics Market Size by Application
9.3.1 Latin America Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Bladder Cancer Molecular Diagnostics Market Size by Country
9.4.1 Latin America Bladder Cancer Molecular Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Bladder Cancer Molecular Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Type
10.2.1 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Application
10.3.1 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Country
10.4.1 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Genetech
11.1.1 Genetech Company Details
11.1.2 Genetech Business Overview
11.1.3 Genetech Bladder Cancer Molecular Diagnostics Introduction
11.1.4 Genetech Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.1.5 Genetech Recent Development
11.2 Gpmedical
11.2.1 Gpmedical Company Details
11.2.2 Gpmedical Business Overview
11.2.3 Gpmedical Bladder Cancer Molecular Diagnostics Introduction
11.2.4 Gpmedical Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.2.5 Gpmedical Recent Development
11.3 Gene+
11.3.1 Gene+ Company Details
11.3.2 Gene+ Business Overview
11.3.3 Gene+ Bladder Cancer Molecular Diagnostics Introduction
11.3.4 Gene+ Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.3.5 Gene+ Recent Development
11.4 DMDbiomed
11.4.1 DMDbiomed Company Details
11.4.2 DMDbiomed Business Overview
11.4.3 DMDbiomed Bladder Cancer Molecular Diagnostics Introduction
11.4.4 DMDbiomed Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.4.5 DMDbiomed Recent Development
11.5 Annoroad
11.5.1 Annoroad Company Details
11.5.2 Annoroad Business Overview
11.5.3 Annoroad Bladder Cancer Molecular Diagnostics Introduction
11.5.4 Annoroad Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.5.5 Annoroad Recent Development
11.6 Topgen
11.6.1 Topgen Company Details
11.6.2 Topgen Business Overview
11.6.3 Topgen Bladder Cancer Molecular Diagnostics Introduction
11.6.4 Topgen Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.6.5 Topgen Recent Development
11.7 Geneis
11.7.1 Geneis Company Details
11.7.2 Geneis Business Overview
11.7.3 Geneis Bladder Cancer Molecular Diagnostics Introduction
11.7.4 Geneis Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.7.5 Geneis Recent Development
11.8 Unitedgene
11.8.1 Unitedgene Company Details
11.8.2 Unitedgene Business Overview
11.8.3 Unitedgene Bladder Cancer Molecular Diagnostics Introduction
11.8.4 Unitedgene Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.8.5 Unitedgene Recent Development
11.9 Inmedi
11.9.1 Inmedi Company Details
11.9.2 Inmedi Business Overview
11.9.3 Inmedi Bladder Cancer Molecular Diagnostics Introduction
11.9.4 Inmedi Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021)
11.9.5 Inmedi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Bladder Cancer Molecular Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of PCR
Table 3. Key Players of FISH
Table 4. Key Players of DNA Sequencing
Table 5. Key Players of Gene Chip
Table 6. Global Bladder Cancer Molecular Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Bladder Cancer Molecular Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Bladder Cancer Molecular Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Bladder Cancer Molecular Diagnostics Market Share by Regions (2016-2021)
Table 10. Global Bladder Cancer Molecular Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Bladder Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Table 12. Bladder Cancer Molecular Diagnostics Market Trends
Table 13. Bladder Cancer Molecular Diagnostics Market Drivers
Table 14. Bladder Cancer Molecular Diagnostics Market Challenges
Table 15. Bladder Cancer Molecular Diagnostics Market Restraints
Table 16. Global Bladder Cancer Molecular Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Bladder Cancer Molecular Diagnostics Market Share by Players (2016-2021)
Table 18. Global Top Bladder Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bladder Cancer Molecular Diagnostics as of 2020)
Table 19. Ranking of Global Top Bladder Cancer Molecular Diagnostics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Bladder Cancer Molecular Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Bladder Cancer Molecular Diagnostics Product Solution and Service
Table 23. Date of Enter into Bladder Cancer Molecular Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Bladder Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Table 27. Global Bladder Cancer Molecular Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Bladder Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Bladder Cancer Molecular Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Bladder Cancer Molecular Diagnostics Revenue Market Share by Application (2016-2021)
Table 31. Global Bladder Cancer Molecular Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Bladder Cancer Molecular Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Bladder Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Bladder Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Bladder Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Bladder Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Bladder Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Bladder Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Genetech Company Details
Table 64. Genetech Business Overview
Table 65. Genetech Bladder Cancer Molecular Diagnostics Product
Table 66. Genetech Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 67. Genetech Recent Development
Table 68. Gpmedical Company Details
Table 69. Gpmedical Business Overview
Table 70. Gpmedical Bladder Cancer Molecular Diagnostics Product
Table 71. Gpmedical Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 72. Gpmedical Recent Development
Table 73. Gene+ Company Details
Table 74. Gene+ Business Overview
Table 75. Gene+ Bladder Cancer Molecular Diagnostics Product
Table 76. Gene+ Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 77. Gene+ Recent Development
Table 78. DMDbiomed Company Details
Table 79. DMDbiomed Business Overview
Table 80. DMDbiomed Bladder Cancer Molecular Diagnostics Product
Table 81. DMDbiomed Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 82. DMDbiomed Recent Development
Table 83. Annoroad Company Details
Table 84. Annoroad Business Overview
Table 85. Annoroad Bladder Cancer Molecular Diagnostics Product
Table 86. Annoroad Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 87. Annoroad Recent Development
Table 88. Topgen Company Details
Table 89. Topgen Business Overview
Table 90. Topgen Bladder Cancer Molecular Diagnostics Product
Table 91. Topgen Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 92. Topgen Recent Development
Table 93. Geneis Company Details
Table 94. Geneis Business Overview
Table 95. Geneis Bladder Cancer Molecular Diagnostics Product
Table 96. Geneis Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 97. Geneis Recent Development
Table 98. Unitedgene Company Details
Table 99. Unitedgene Business Overview
Table 100. Unitedgene Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 101. Unitedgene Recent Development
Table 102. Inmedi Company Details
Table 103. Inmedi Business Overview
Table 104. Inmedi Bladder Cancer Molecular Diagnostics Product
Table 105. Inmedi Revenue in Bladder Cancer Molecular Diagnostics Business (2016-2021) & (US$ Million)
Table 106. Inmedi Recent Development
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Bladder Cancer Molecular Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. PCR Features
Figure 3. FISH Features
Figure 4. DNA Sequencing Features
Figure 5. Gene Chip Features
Figure 6. Global Bladder Cancer Molecular Diagnostics Market Share by Application: 2020 VS 2027
Figure 7. Clinical Diagnosis Case Studies
Figure 8. Drug Screening Case Studies
Figure 9. Research Case Studies
Figure 10. Bladder Cancer Molecular Diagnostics Report Years Considered
Figure 11. Global Bladder Cancer Molecular Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Bladder Cancer Molecular Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Bladder Cancer Molecular Diagnostics Market Share by Regions: 2020 VS 2027
Figure 14. Global Bladder Cancer Molecular Diagnostics Market Share by Regions (2022-2027)
Figure 15. Global Bladder Cancer Molecular Diagnostics Market Share by Players in 2020
Figure 16. Global Top Bladder Cancer Molecular Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bladder Cancer Molecular Diagnostics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Bladder Cancer Molecular Diagnostics Revenue in 2020
Figure 18. Global Bladder Cancer Molecular Diagnostics Revenue Market Share by Type (2016-2021)
Figure 19. Global Bladder Cancer Molecular Diagnostics Revenue Market Share by Type (2022-2027)
Figure 20. North America Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Bladder Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 22. North America Bladder Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 23. North America Bladder Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 24. United States Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Bladder Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 28. Europe Bladder Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 29. Europe Bladder Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 30. Germany Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Bladder Cancer Molecular Diagnostics Market Share by Region (2016-2027)
Figure 40. China Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Bladder Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 48. Latin America Bladder Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 49. Latin America Bladder Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 50. Mexico Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Bladder Cancer Molecular Diagnostics Market Share by Country (2016-2027)
Figure 56. Turkey Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Bladder Cancer Molecular Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Genetech Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 60. Gpmedical Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 61. Gene+ Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 62. DMDbiomed Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 63. Annoroad Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 64. Topgen Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 65. Geneis Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 66. Unitedgene Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 67. Inmedi Revenue Growth Rate in Bladder Cancer Molecular Diagnostics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年）

Global Laryngeal Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4412 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、喉頭がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年）

Global Pancreatic Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4649 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、膵臓がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の肝がん分子診断市場規模・現状・予測（2021年-2027年）

Global Liver Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4434 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、肝がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年）

Global Thyroid Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4953 2021年6月 109Pages
QYResearch社発行の本調査レポートでは、甲状腺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米...

世界の卵巣がん分子診断市場規模・現状・予測（2021年-2027年）

Global Ovarian Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4637 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、卵巣がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の肺がん分子診断市場規模・現状・予測（2021年-2027年）

Global Lung Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4443 2021年6月 108Pages
QYResearch社発行の本調査レポートでは、肺がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の胃がん分子診断市場規模・現状・予測（2021年-2027年）

Global Stomach Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-4909 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、胃がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、ア...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の筋層浸潤性膀胱がん治療市場規模・現状・予測（2021年-2027年）

Global Muscle Invasive Bladder Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5259 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、筋層浸潤性膀胱がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ネオアジュバント化学療法、術後化学療法）、用途別市場規模（病院、研究所、専門クリニック）、主要地域別市場規模（北米、アメリカ、欧州...

世界の胆嚢がん分子診断市場規模・現状・予測（2021年-2027年）

Global Molecular Diagnosis of Gallbladder Cancer Market Size, Status and Forecast 2021-2027
QFJ1-4516 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、胆嚢がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing laryngeal cancer Market Analysis and Insights: Global Laryngeal Cancer Molecular Diagnostics Market The global Laryngeal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…
世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
世界の甲状腺がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing thyroid cancer Market Analysis and Insights: Global Thyroid Cancer Molecular Diagnostics Market The global Thyroid Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の胃がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing stomach cancer Market Analysis and Insights: Global Stomach Cancer Molecular Diagnostics Market The global Stomach Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…